$AVXS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AveXis, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AveXis, Inc.. Get notifications about new insider transactions in AveXis, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 180,274 | |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 122.83 | 17 | 2,088 | 0 | 17 to 0 (-100.00 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 120.79 | 258 | 31,164 | 17 | 275 to 17 (-93.82 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 118.96 | 3 | 357 | 275 | 278 to 275 (-1.08 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 118.01 | 501 | 59,123 | 278 | 779 to 278 (-64.31 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 117.12 | 1,001 | 117,237 | 779 | 1.8 K to 779 (-56.24 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 122.83 | 100 | 12,283 | 1,781,802 | 1.8 M to 1.8 M (-0.01 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 121.95 | 208 | 25,366 | 1,781,902 | 1.8 M to 1.8 M (-0.01 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 121.17 | 918 | 111,234 | 1,782,110 | 1.8 M to 1.8 M (-0.05 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 120.14 | 993 | 119,299 | 1,783,028 | 1.8 M to 1.8 M (-0.06 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 118.67 | 908 | 107,752 | 1,784,021 | 1.8 M to 1.8 M (-0.05 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 117.79 | 7,218 | 850,208 | 1,784,929 | 1.8 M to 1.8 M (-0.40 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 117.05 | 4,655 | 544,868 | 1,792,147 | 1.8 M to 1.8 M (-0.26 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | M | 18.17 | 2,000 | 36,340 | 145,800 | |
Feb 05 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 122.83 | 20 | 2,457 | 5,000 | 5 K to 5 K (-0.40 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 121.77 | 155 | 18,874 | 5,020 | 5.2 K to 5 K (-3.00 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 119.74 | 176 | 21,074 | 5,175 | 5.4 K to 5.2 K (-3.29 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 118.03 | 758 | 89,467 | 5,351 | 6.1 K to 5.4 K (-12.41 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 117.15 | 891 | 104,381 | 6,109 | 7 K to 6.1 K (-12.73 %) |
Feb 05 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Buy | M | 18.17 | 2,000 | 36,340 | 7,000 | 5 K to 7 K (+40.00 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | M | 18.17 | 5,000 | 90,850 | 146,800 | |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 112.50 | 50 | 5,625 | 0 | 50 to 0 (-100.00 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 111.41 | 126 | 14,038 | 50 | 176 to 50 (-71.59 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 110.30 | 100 | 11,030 | 176 | 276 to 176 (-36.23 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 109.75 | 963 | 105,689 | 276 | 1.2 K to 276 (-77.72 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 108.14 | 1,019 | 110,195 | 1,239 | 2.3 K to 1.2 K (-45.13 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 106.49 | 84 | 8,945 | 2,258 | 2.3 K to 2.3 K (-3.59 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 105.89 | 624 | 66,075 | 2,342 | 3 K to 2.3 K (-21.04 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 104.64 | 1,074 | 112,383 | 2,966 | 4 K to 3 K (-26.58 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 103.56 | 464 | 48,052 | 4,040 | 4.5 K to 4 K (-10.30 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 101.99 | 496 | 50,587 | 4,504 | 5 K to 4.5 K (-9.92 %) |
Jan 18 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Buy | M | 18.17 | 5,000 | 90,850 | 5,000 | 0 to 5 K |
Jan 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | M | 18.17 | 2,000 | 36,340 | 147,800 | |
Jan 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 110.35 | 640 | 70,624 | 5,000 | 5.6 K to 5 K (-11.35 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 109.48 | 1,235 | 135,208 | 5,640 | 6.9 K to 5.6 K (-17.96 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 108.64 | 125 | 13,580 | 6,875 | 7 K to 6.9 K (-1.79 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Buy | M | 18.17 | 2,000 | 36,340 | 7,000 | 5 K to 7 K (+40.00 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 182,054 | |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 110.21 | 684 | 75,384 | 0 | 684 to 0 (-100.00 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 109.42 | 1,096 | 119,924 | 684 | 1.8 K to 684 (-61.57 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Jan 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 110.58 | 1,838 | 203,246 | 1,796,802 | 1.8 M to 1.8 M (-0.10 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 109.87 | 9,746 | 1,070,793 | 1,798,640 | 1.8 M to 1.8 M (-0.54 %) |
Jan 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 108.95 | 3,416 | 372,173 | 1,808,386 | 1.8 M to 1.8 M (-0.19 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | M | 18.17 | 2,000 | 36,340 | 149,800 | |
Dec 05 2017 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 96.81 | 129 | 12,488 | 5,000 | 5.1 K to 5 K (-2.52 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 96.01 | 359 | 34,468 | 5,129 | 5.5 K to 5.1 K (-6.54 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 94.43 | 437 | 41,266 | 5,488 | 5.9 K to 5.5 K (-7.38 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 93.71 | 1,075 | 100,738 | 5,925 | 7 K to 5.9 K (-15.36 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Buy | M | 18.17 | 2,000 | 36,340 | 7,000 | 5 K to 7 K (+40.00 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 95.95 | 1,134 | 108,807 | 1,811,802 | 1.8 M to 1.8 M (-0.06 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 95.00 | 9,810 | 931,950 | 1,812,936 | 1.8 M to 1.8 M (-0.54 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 94.14 | 2,685 | 252,766 | 1,822,746 | 1.8 M to 1.8 M (-0.15 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 93.27 | 1,071 | 99,892 | 1,825,431 | 1.8 M to 1.8 M (-0.06 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 91.84 | 300 | 27,552 | 1,826,502 | 1.8 M to 1.8 M (-0.02 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 183,834 | |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 95.81 | 135 | 12,934 | 0 | 135 to 0 (-100.00 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 94.92 | 1,327 | 125,959 | 135 | 1.5 K to 135 (-90.77 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 93.72 | 318 | 29,803 | 1,462 | 1.8 K to 1.5 K (-17.87 %) |
Dec 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 185,614 | |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 106.26 | 70 | 7,438 | 0 | 70 to 0 (-100.00 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 105.02 | 205 | 21,529 | 70 | 275 to 70 (-74.55 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 104.06 | 149 | 15,505 | 275 | 424 to 275 (-35.14 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 102.00 | 42 | 4,284 | 424 | 466 to 424 (-9.01 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 100.70 | 631 | 63,542 | 466 | 1.1 K to 466 (-57.52 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 100.05 | 431 | 43,122 | 1,097 | 1.5 K to 1.1 K (-28.21 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 98.51 | 252 | 24,825 | 1,528 | 1.8 K to 1.5 K (-14.16 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 106.17 | 545 | 57,863 | 1,826,802 | 1.8 M to 1.8 M (-0.03 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 105.40 | 766 | 80,736 | 1,827,347 | 1.8 M to 1.8 M (-0.04 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 104.67 | 1,463 | 153,132 | 1,828,113 | 1.8 M to 1.8 M (-0.08 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 103.16 | 513 | 52,921 | 1,829,576 | 1.8 M to 1.8 M (-0.03 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 102.13 | 1,071 | 109,381 | 1,830,089 | 1.8 M to 1.8 M (-0.06 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.77 | 2,128 | 214,439 | 1,831,160 | 1.8 M to 1.8 M (-0.12 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.24 | 6,453 | 646,849 | 1,833,288 | 1.8 M to 1.8 M (-0.35 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 98.85 | 1,278 | 126,330 | 1,839,741 | 1.8 M to 1.8 M (-0.07 %) |
Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 98.04 | 783 | 76,765 | 1,841,019 | 1.8 M to 1.8 M (-0.04 %) |
Oct 20 2017 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | A | 100.52 | 10,000 | 1,005,200 | 10,000 | |
Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 103.60 | 1,175 | 121,730 | 1,841,802 | 1.8 M to 1.8 M (-0.06 %) |
Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 102.70 | 1,559 | 160,109 | 1,842,977 | 1.8 M to 1.8 M (-0.08 %) |
Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 101.55 | 6,767 | 687,189 | 1,844,536 | 1.9 M to 1.8 M (-0.37 %) |
Oct 11 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.53 | 5,499 | 552,814 | 1,851,303 | 1.9 M to 1.9 M (-0.30 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 187,394 | |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 99.26 | 170 | 16,874 | 0 | 170 to 0 (-100.00 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 98.77 | 385 | 38,026 | 170 | 555 to 170 (-69.37 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 96.98 | 587 | 56,927 | 555 | 1.1 K to 555 (-51.40 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 96.05 | 638 | 61,280 | 1,142 | 1.8 K to 1.1 K (-35.84 %) |
Oct 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 189,174 | |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 93.91 | 574 | 53,904 | 0 | 574 to 0 (-100.00 %) |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 92.93 | 1,206 | 112,074 | 574 | 1.8 K to 574 (-67.75 %) |
Sep 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 190,954 | |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 92.75 | 17 | 1,577 | 0 | 17 to 0 (-100.00 %) |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 91.92 | 696 | 63,976 | 17 | 713 to 17 (-97.62 %) |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 91.24 | 1,067 | 97,353 | 713 | 1.8 K to 713 (-59.94 %) |
Aug 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 194,514 | |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 71.91 | 170 | 12,225 | 0 | 170 to 0 (-100.00 %) |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 71.19 | 977 | 69,553 | 170 | 1.1 K to 170 (-85.18 %) |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 70.20 | 633 | 44,437 | 1,147 | 1.8 K to 1.1 K (-35.56 %) |
Jun 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Jun 01 2017 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | A | 69.25 | 5,301 | 367,094 | 5,301 | |
Jun 01 2017 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Jun 01 2017 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Jun 01 2017 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Jun 01 2017 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Jun 01 2017 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
Jun 01 2017 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 69.25 | 2,454 | 169,940 | 2,454 | |
May 12 2017 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | A | 77.24 | 27,827 | 2,149,357 | 27,827 | |
May 12 2017 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Option Exercise | A | 77.24 | 1,925 | 148,687 | 1,925 | |
May 12 2017 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Option Exercise | A | 77.24 | 22,500 | 1,737,900 | 22,500 | |
May 12 2017 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Option Exercise | A | 77.24 | 1,282 | 99,022 | 1,282 | |
May 12 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | A | 77.24 | 32,501 | 2,510,377 | 32,501 | |
May 12 2017 | AVXS | AveXis, Inc. | Dee Thomas J. | Sr. VP & CFO | Option Exercise | A | 77.24 | 25,200 | 1,946,448 | 25,200 | |
May 12 2017 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | A | 77.24 | 27,827 | 2,149,357 | 27,827 | |
May 12 2017 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Option Exercise | A | 77.24 | 7,940 | 613,286 | 7,940 | |
May 12 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 77.24 | 25,200 | 1,946,448 | 25,200 | |
May 12 2017 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | A | 77.24 | 96,000 | 7,415,040 | 96,000 | |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 196,294 | |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 82.58 | 22 | 1,817 | 0 | 22 to 0 (-100.00 %) |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 81.91 | 576 | 47,180 | 22 | 598 to 22 (-96.32 %) |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 81.11 | 1,182 | 95,872 | 598 | 1.8 K to 598 (-66.40 %) |
May 02 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
Apr 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,781 | 32,895 | 198,074 | |
Apr 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 76.13 | 1,781 | 135,588 | 0 | 1.8 K to 0 (-100.00 %) |
Apr 05 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,781 | 32,895 | 1,781 | 0 to 1.8 K |
Mar 23 2017 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Option Exercise | A | 79.75 | 35,950 | 2,867,013 | 35,950 | |
Feb 15 2017 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Option Exercise | A | 57.79 | 61,000 | 3,525,190 | 61,000 | |
Sep 15 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | S | 34.50 | 289,855 | 9,999,998 | 1,201,160 | 1.5 M to 1.2 M (-19.44 %) |
Aug 22 2016 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Buy | P | 20.00 | 5,000 | 100,000 | 5,000 | 0 to 5 K |
Jul 07 2016 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Option Exercise | A | 36.02 | 44,700 | 1,610,094 | 44,700 | |
Jun 22 2016 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | A | 42.61 | 37,750 | 1,608,528 | 37,750 | |
Jun 22 2016 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | A | 42.61 | 37,750 | 1,608,528 | 37,750 | |
Jun 22 2016 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 42.61 | 37,750 | 1,608,528 | 37,750 | |
Jun 22 2016 | AVXS | AveXis, Inc. | Dee Thomas J. | Sr. VP & CFO | Option Exercise | A | 42.61 | 37,750 | 1,608,528 | 37,750 | |
Jun 22 2016 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | A | 42.61 | 110,000 | 4,687,100 | 110,000 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 137,154 | 352,486 | 137,154 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 130,623 | 335,701 | 130,623 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 137,154 | 352,486 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 2.57 | 130,623 | 335,701 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 0.00 | 1,659,237 | 0 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 0.00 | 941 | 0 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | C | 0.00 | 8,469 | 0 | 0 | |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Buy | C | 0.00 | 1,659,237 | 0 | 1,659,237 | 0 to 1.7 M |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Buy | C | 0.00 | 941 | 0 | 25,293 | 24.4 K to 25.3 K (+3.86 %) |
Feb 19 2016 | AVXS | AveXis, Inc. | Manning Paul B | Director | Buy | C | 0.00 | 8,469 | 0 | 227,646 | 219.2 K to 227.6 K (+3.86 %) |